accountsite and country feasibility; data management and reporting set-up; program study drug logistics; scientific and medical communications; and quality assurance. Peter Gray, CEO at ICON plc, commented, ���Today���s announcement is another significant...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to ICON Selected By Pfizer As A Global Strategic Partner For Clinical Research And Development
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account